Ovarian tissue cryopreservation for cancer patients: who is appropriate?

Abstract

In recent decades there has been parallel progress in the fields of cancer chemotherapy and reproductive medicine technology, which has led to increasing numbers of women surviving their malignancies, often with significant reproductive impairment, and a range of choices for the potential preservation of fertility, including storage of embryos, mature oocytes, immature oocytes or ovarian tissue. Although each of these procedures has specific relative advantages and disadvantages, there are no clear guidelines for selection of patients for such interventions. There are six distinct issues that should be considered before making any recommendations regarding the appropriateness of any of the r..